Novo Nordisk A/S (NVO)
Pre-Market:
| Previous Close | 128.31 |
| Open | 127.80 |
| Bid | 127.74 x 1200 |
| Ask | 127.96 x 800 |
| Day's Range | 127.50 - 130.13 |
| 52 Week Range | 75.56 - 138.28 |
| Volume | |
| Avg. Volume | 4,844,585 |
| Market Cap | 578.54B |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | 48.39 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.37 (1.06%) |
| Ex-Dividend Date | Mar 22, 2024 |
| 1y Target Est | N/A |
- Yahoo Finance Video
Apple earnings on tap, investors digest Fed decision: Yahoo Finance
It's a busy day on Wall Street with investors bracing for earnings from numerous top names, including Apple (AAPL), Coinbase (COIN), Block (SQ), DraftKings (DKNG), Peloton (PTON), Novo Nordisk (NVO), and Moderna (MRNA). Apple is in focus, with investors bracing for key sales numbers out of China. Traders are still digesting the Federal Reserve's decision to leave interest rates unchanged at a 23-year high of 5.25%-5.50%. During his press conference yesterday, Chair Jerome Powell hinted that the central bank's next move will unlikely be a rate hike. Yahoo Finance trending tickers include Carvana (CVNA), NIO (NIO), and Qualcomm (QCOM). Key guests include:9 a.m. ET - Gabriela Santos, J.P. Morgan Asset Management Chief Global Strategist for the Americas9:15 a.m. ET - Lars Fruergaard Jørgensen, Novo Nordisk CEO10 a.m. ET - Deepak Puri, Deutsche Bank CIO Americas10:15 a.m. ET - Akash Palkhiwala, Qualcomm CFO10:30 a.m. ET - John Rogers, Ariel Investments Co-CEO10:40 a.m. ET - Stéphane Bancel, Moderna CEO10:50 a.m. ET - Stephen Yalof, Tanger CEO11:15 a.m. ET - Michael Skipworth, Wingstop CEO
- Yahoo Finance Video
Apple, Novo Nordisk earnings, jobless claims: What to watch
A number of companies release their quarterly earning reports on Thursday, including Apple (AAPL), Novo Nordisk (NVO), Shell (SHEL), ConocoPhillips (COP), Cigna (CI), Coinbase (COIN), Moderna (MRNA), DraftKings (DKNG), Kellanova (K), United States Steel (X), and more. On the economic front, jobless claims for the week ending on April 27 will be released. Economists expect claims to rise to 212,000 from 207,000 the prior week. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino
- Reuters
UPDATE 1-Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1
Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have increased, a senior executive said on Thursday. Wegovy prices in the United States were "slightly down" in the first quarter and Novo expects further decreases through the rest of 2024, Chief Financial Officer Karsten Munk Knudsen said on a call with media.
